S792-0220 Screening compound: (9AS13AS)-N-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-9-OXO-1-[(PYRIDIN-4-YL)METHYL]-TETRADECAHYDRO-1H-PYRIDO[34-B]15-DIAZACYCLOUNDECANE-12-CARBOXAMIDE

S792-0220 Screening compound: (9AS13AS)-N-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-9-OXO-1-[(PYRIDIN-4-YL)METHYL]-TETRADECAHYDRO-1H-PYRIDO[34-B]15-DIAZACYCLOUNDECANE-12-CARBOXAMIDE
S792-0220 Screening compound: (9AS13AS)-N-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-9-OXO-1-[(PYRIDIN-4-YL)METHYL]-TETRADECAHYDRO-1H-PYRIDO[34-B]15-DIAZACYCLOUNDECANE-12-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound S792-0220
(9AS13AS)-N-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-9-OXO-1-[(PYRIDIN-4-YL)METHYL]-TETRADECAHYDRO-1H-PYRIDO[34-B]15-DIAZACYCLOUNDECANE-12-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S792-0220

Molecular Formula

C27H35N5O4 (C27 H35 N5 O4)

Compound Name

(9AS13AS)-N-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-9-OXO-1-[(PYRIDIN-4-YL)METHYL]-TETRADECAHYDRO-1H-PYRIDO[34-B]15-DIAZACYCLOUNDECANE-12-CARBOXAMIDE

IUPAC name

(9aS13aS)-N-(23-dihydro-14-benzodioxin-6-yl)-9-oxo-1-[(pyridin-4-yl)methyl]-tetradecahydro-1H-pyrido[34-b]15-diazacycloundecane-12-carboxamide

SMILES

O=C(Nc(cc1)cc2c1OCCO2)N(CC[C@@H]12)C[C@@H]2N(Cc2ccncc2)CCCCCCNC1=O

InChI

InChI=1S/C27H35N5O4/c33-26-22-9-14-32(27(34)30-21-5-6-24-25(17-21)36-16-15-35-24)19-23(22)31(13-4-2-1-3-10-29-26)18-20-7-11-28-12-8-20/h5-8,11-12,17,22-23H,1-4,9-10,13-16,18-19H2,(H,29,33)(H,30,34)/t22-,23+/m1/s1

InChI Key

UNFCDZFVILXLCM-PKTZIBPZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.127

Distribution Coefficient, logD

0.906

Water Solubility, LogSw

-2.04

Polar Surface Area

79.220

Acid Dissociation Constant (pKa)

12.72

Base Dissociation Constant (pKb)

7.22

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

51.85

S792-0220 in Drug Discovery

Included in Screening Libraries

Macrocycles Library (2450 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with S792-0220 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S792-0220?
Check Price and Availability of S792-0220, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S792-0220 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S792-0220
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S792-0220
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S792-0220 available by request